BIOPSY SCIENCES, LLC
CLEARWATER, FLORIDA

BIOPSY SCIENCES, LLC is a well-regarded company in the medical technology field, founded by Dr. John Fisher, an expert interventional radiologist specializing in breast imaging and biopsy techniques. Established on December 28, 2000, in Clearwater, Florida, the company sits at 4900 Creekside Drive, Suite C, marking its presence as a model Florida Company. Under Dr. Fisher's leadership, known for carrying out over 500 stereotactic and ultrasound-guided breast biopsies, BIOPSY SCIENCES initiated groundbreaking developments like the HydroMARK. This innovative water-containing, ultrasound-visible marker was designed to make patient experiences more comfortable by speeding up localization processes compared to standard mammogram guided techniques. In another leap forward for medical advancements, the team developed BioSEAL, a biopsy tract sealant that significantly reduces complications from CT directed lung biopsies, such as pneumothorax and post-procedure chest tube placements. This innovation in patient care was so impactful that Angiotech Pharmaceuticals acquired it in 2008. BIOPSY SCIENCES remains committed to advancing medical technology under the continued guidance of Dr. Fisher and his dedicated team management with James C Gibson, John S Fisher, and Fred Ahari. The company prioritizes addressing clinical needs through innovative solutions while upholding transparent communication channels for all stakeholder interactions. They can be reached via phone at (888) 819-1073, (727) 290-9825, or (727) 290-9828, or through email contact as detailed on their website, biopsysciences.com.